Not a good buy right now for an impatient entry: price is pressing near-term resistance (~80.73) after a bullish run, while the most recent Street downgrade (JPM) places fair value only slightly above the current price.
Trend is still bullish (SMA alignment + positive/expanding MACD), so this is not a sell; it’s a “wait for either a breakout above ~80.7–82.2 or a pullback toward ~78.4 support” setup.
Options positioning shows call-heavy open interest (put/call OI 0.26) but elevated IV percentile (~72.5) suggests the market is paying up for protection/event risk into the next earnings window.
Momentum: MACD histogram at 0.262 and expanding above zero = bullish momentum still building.
RSI: RSI_6 ~64.6 (neutral-to-warm) = not overbought yet, but closer to “extended” than “cheap.”
Levels: Pivot support ~78.39 (key near-term hold level); Resistance R1 ~80.73 and R2 ~82.18. Current price (80.26) is just below R1, which often caps immediate upside.
Pattern-based forward odds (given): statistical tilt bullish (60% chance of +3.27% next day, +4.12% next week, +6.01% next month), but near-resistance placement makes the immediate risk/reward less attractive for a chase entry.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/Sentiment: Open interest is call-skewed (put/call OI 0.26) = bullish longer-dated positioning.
Flow today: Put/call volume ratio 0.77 = slightly more calls than puts, but not extreme.
Volatility: IV 30D ~32.08 with IV percentile ~72.51 = options are relatively expensive vs the past year, consistent with elevated event/earnings premium.
Activity: Volume vs 30-day average is very high (17.15x), indicating unusual attention; this often appears ahead of catalysts and can amplify post-event moves.
Technical Summary
Sell
4
Buy
10
Positive Catalysts
No notable negative insider/hedge fund trend flagged in provided data (both marked Neutral).
Margin: Gross margin 26.57%, down 22.49% YoY (growth is strong, but profitability efficiency compressed—worth watching into the next earnings season).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Recent trend: price targets have generally been trimmed/normalized (UBS 114→103; MS 107→104; JPM 87→83 with a downgrade), suggesting less enthusiasm for near-term upside even among bulls.
Current split:
Bullish: Morgan Stanley Overweight ($104), UBS Buy ($103), Scotiabank Outperform ($91).
Neutral/Hold: JPMorgan Neutral ($83), Jefferies Hold ($80).
Wall Street cons view (cons): nearer-term macro/commodity sensitivity and weaker crude pricing may limit throughput/guidance confidence; recent guidance/EBITDA misses cited by JPM dampen sentiment.
Wall Street analysts forecast OKE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OKE is 86 USD with a low forecast of 75 USD and a high forecast of 110 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
12 Analyst Rating
Wall Street analysts forecast OKE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OKE is 86 USD with a low forecast of 75 USD and a high forecast of 110 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Buy
5 Hold
0 Sell
Moderate Buy
Current: 80.460
Low
75
Averages
86
High
110
Current: 80.460
Low
75
Averages
86
High
110
Morgan Stanley
Robert Kad
Overweight
downgrade
$107 -> $104
AI Analysis
2026-01-28
Reason
Morgan Stanley
Robert Kad
Price Target
$107 -> $104
AI Analysis
2026-01-28
downgrade
Overweight
Reason
Morgan Stanley analyst Robert Kad lowered the firm's price target on Oneok to $104 from $107 and keeps an Overweight rating on the shares. The firm is updating its price targets for North American Midstream & Renewable Energy Infrastructure stocks under its coverage, the analyst tells investors. Morgan Stanley notes the earnings season started with strong results and the energy sector had led performance in the S&P given strength across commodity prices.
JPMorgan
Jeremy Tonet
Overweight -> Neutral
downgrade
$87 -> $83
2026-01-27
Reason
JPMorgan
Jeremy Tonet
Price Target
$87 -> $83
2026-01-27
downgrade
Overweight -> Neutral
Reason
JPMorgan analyst Jeremy Tonet downgraded Oneok to Neutral from Overweight with a price target of $83, down from $87. The company's recent results have missed its EBITDA guidance amid soft macro fundamentals, the analyst tells investors in a research note. The firm believes improved sentiment on the stock may require improved oil prices. As such, JPMorgan sees better opportunity elsewhere in its coverage universe.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for OKE
